Nexvet Biopharma plc 4
4 · Nexvet Biopharma plc · Filed Jul 5, 2017
Insider Transaction Report
Form 4
PAYNE JOHN BERNARD
Director
Transactions
- Exercise/Conversion
Restricted Share Units
2017-07-01−3,600→ 0 totalExercise: $0.13From: 2017-07-01Exp: 2021-07-01→ Ordinary Shares (3,600 underlying) - Exercise/Conversion
Ordinary Shares
2017-07-01$0.13/sh+3,600$450→ 10,800 total
Holdings
- 6,195(indirect: John B. Payne Living A/C)
Ordinary Shares
Footnotes (1)
- [F1]The reporting person has sole voting and dispositive power with respect to these reported securities.